North Star Investment Management’s Acadia Pharmaceuticals ACAD Stock Holding History

North Star Investment Management’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-880	Closed	-$38K	–	992
2019 Q4	$38K	Hold	880	–	–	﹤0.01%	601
2019 Q3	$32K	Buy	+880	New	+$26.7K	﹤0.01%	625
2019 Q2	–	Sell	-880	Closed	-$24K	–	393
2019 Q1	$24K	Hold	880	–	–	﹤0.01%	690
2018 Q4	$14K	Hold	880	–	–	﹤0.01%	736
2018 Q3	$18K	Hold	880	–	–	﹤0.01%	738
2018 Q2	$13K	Hold	880	–	–	﹤0.01%	797
2018 Q1	$20K	Hold	880	–	–	﹤0.01%	731
2017 Q4	$26K	Hold	880	–	–	﹤0.01%	669
2017 Q3	$33K	Hold	880	–	–	﹤0.01%	616
2017 Q2	$25K	Hold	880	–	–	﹤0.01%	666
2017 Q1	$30K	Hold	880	–	–	﹤0.01%	603
2016 Q4	$25K	Hold	880	–	–	﹤0.01%	599
2016 Q3	$28K	Hold	880	–	–	0.01%	483
2016 Q2	$29K	Hold	880	–	–	0.01%	475
2016 Q1	$25K	Hold	880	–	–	﹤0.01%	472
2015 Q4	$31K	Hold	880	–	–	0.01%	446
2015 Q3	$29K	Hold	880	–	–	0.01%	456
2015 Q2	$37K	Hold	880	–	–	0.01%	422
2015 Q1	$29K	Hold	880	–	–	0.01%	438
2014 Q4	$28K	Hold	880	–	–	0.01%	437
2014 Q3	$22K	Hold	880	–	–	﹤0.01%	449
2014 Q2	$20K	Hold	880	–	–	﹤0.01%	486
2014 Q1	$21K	Buy	+880	New	+$22.3K	﹤0.01%	464

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

North Star Investment Management's ACAD Position: Q1 2020 in Review

North Star Investment Management sold out of Acadia Pharmaceuticals (ACAD) in Q1 2020, closing a stake of 880 shares — an estimated $38K sold.

North Star Investment Management first reported a position in ACAD in Q1 2014 and held it in 23 quarters. The position peaked at $38K in Q4 2019. 245 funds tracked by Wall St. Rank hold ACAD as of Q1 2020.

North Star Investment Management reported no remaining Acadia Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
North Star Investment Management sold 880 Acadia Pharmaceuticals shares in Q1 2020, an estimated $38K.
North Star Investment Management first reported a position in Acadia Pharmaceuticals in Q1 2014 and held it in 23 quarters.
North Star Investment Management's Acadia Pharmaceuticals position peaked at $38K in Q4 2019.
245 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2020.

Based on North Star Investment Management's 13F filing for Q1 2020, filed 23 Apr 2020.